-

Surescripts RxTransfer Saves Time for Pharmacists and Prescribers with Seamless Communication, Ensuring Patients Have Access to Needed Medications Without Delay

ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts®, the nation’s leading health intelligence network, announced strong adoption of RxTransfer, including across 4,800 Walmart locations, enabling pharmacies nationwide to electronically transfer prescriptions quickly and accurately.

“Innovation continues to be a critical priority for Surescripts, and we are proud of the growing impact of our E-Prescribing solution and RxTransfer transaction, saving time for pharmacists and prescribers," said Lawrence King, VP Product, Surescripts.

Share

In January 2026, pharmacies completed more than 542,202 RxTransfer transactions, more than double the number completed in 2025, as additional pharmacies became enabled with this technology.

These transactions often replace manual fax‑ or phone‑based prescription transfers with a standardized electronic workflow, providing a seamless connection between prescribers and pharmacists, ensuring greater access to medications and treatment continuity for patients.

“Innovation continues to be a critical priority for Surescripts, and we are proud of the growing impact of our E-Prescribing solution and RxTransfer transaction, saving time for pharmacists and prescribers, simultaneously improving workflow efficiency and patient safety,” said Lawrence King, Vice President of Product Innovation, Intelligent Prescribing at Surescripts. “More importantly, standardized tools like RxTransfer bring greater prescription accuracy and help patients access needed medications without delay, improving adherence that can lead to better care outcomes.”

“RxTransfer is eliminating one of the most persistent bottlenecks in pharmacy workflow that has traditionally required faxes and phone calls to transfer prescriptions, giving back time to pharmacists and improving access to needed prescriptions for patients,” said Walker Arp, Senior Product Analyst, Intelligent Prescribing for Surescripts. “We’re especially proud of the impact we’ve achieved because it demonstrates what is possible when we collaborate across the Surescripts Network Alliance and work towards a shared purpose of improving patient care.”

Key Impacts:

  • 542,202 RxTransfer transactions completed in January 2026, more than double the number in 2025, which totaled 201,999.
  • Nearly 25% of retail pharmacies on the Surescripts network are enabled with RxTransfer, up from 6% in 2024, according to a recent report.
  • 75% of RxTransfer requests receive a response within an hour.

These results reflect a growing shift toward digital, interoperable pharmacy workflows that reduce administrative burden, shorten handoff times, and help ensure patients receive medications as quickly and accurately as possible.

Surescripts RxTransfer is standardized to enable seamless communication between prescribers and pharmacists and provides greater prescription accuracy, workflow efficiency and patient safety.

How it works: If a medication is out of stock or if a patient is traveling or has moved to another state, RxTransfer allows pharmacists to request that the prescription be transferred to another pharmacy.

For Media

Catch up with Surescripts leaders, including Lawrence King, Vice President of Product Innovation, Intelligent Prescribing at Surescripts, at NACDS Annual, April 18-21. Please contact Kate Giaquinto to schedule an interview.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we bring healthcare together to inform and accelerate decisions, helping keep patient care on track. With the Surescripts Network Alliance®, we’re empowering the healthcare ecosystem with intelligence and interoperability for smarter, faster prescribing, prior authorization, treatment, care management and more. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Media Contact:
Kate Giaquinto
(571) 290-6859
Kate.Giaquinto@surescripts.com

Surescripts


Release Versions
Hashtags

Contacts

Media Contact:
Kate Giaquinto
(571) 290-6859
Kate.Giaquinto@surescripts.com

Social Media Profiles
More News From Surescripts

Surescripts Annual Impact Report Shows Collaboration, Innovation Gains in Interoperability, Prior Authorization Automation and Medication Access in 2025

ARLINGTON, Va.--(BUSINESS WIRE)--Surescripts®, the nation’s leading health intelligence network, today released its Annual Impact Report 2025, highlighting record advancements in health data interoperability, enhanced efficiency for care providers, and faster, more affordable access to prescription therapy for patients nationwide. New Data: Surescripts Annual Impact Report 2025 “When we talk about advancing healthcare interoperability, we are talking about strengthening the connection between p...

Survey Shows U.S. Patients Struggle with Prescription Costs That Limit Treatment Access, While Demand Grows for Digital Tools to Unlock Price Transparency

ARLINGTON, Va.--(BUSINESS WIRE)--A new national survey of 1,007 U.S. adults who have interacted with the US healthcare system in the past 12 months, conducted by The Harris Poll on behalf of Surescripts®, finds that more than half of patients experience challenges when filling prescriptions and uncertainty about who to trust for prescription medication information or costs, leading one in four patients to abandon a prescription because it was too expensive. Despite these barriers, 77% of patien...

Surescripts and GoodRx Partner to Advance Patient Price Transparency

ARLINGTON, Va. & SANTA MONICA, Calif.--(BUSINESS WIRE)--Surescripts®, the nation’s leading health intelligence network, introduces its Patient Experience product, Script Corner™, to transform the medication experience and empower patients by bringing together prescription benefit data, medication management and personalized engagement. Script Corner will include patient price transparency, including discounted cash prices through an exclusive partnership with GoodRx (Nasdaq: GDRX), the leading...
Back to Newsroom